Human Immune Receptor Expressed On Myeloid Cells 1 (IREM1) ELISA Kit

Human Immune Receptor Expressed On Myeloid Cells 1 (IREM1) ELISA Kit

Size

96 Tests

Catalog no.

RD-IREM1-Hu

Price

768 EUR

Buy
NameValue
Tissue cells
UniProtKB Q8TDQ1
Gene ID 146722
Experimental Method sandwich
Shelf Life 12 months
Sensitivity 0.062ng/mL
Detection Range 0.156-10ng/mL
Species Reactivity Homo sapiens human
Test ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Recommended Sample Type tissue homogenates, cell lysates and other biological fluids.
Note This product is available in other size, contact us for more information
Alternatives CD300f,CD300LF,NKIR,IGSF13,CLM1,CD300 Antigen Like Family Member F,CMRF35-Like Molecule 1,Immunoglobulin superfamily member 13,NK inhibitory receptor
Properties E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Description Complexes, systems, regulators, immune RNAs and non immune controls that can react with a specific antigen epitope.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.